Clinical Trial Update: Nadroparin for the Initial Treatment of Pulmonary Thromboembolism [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating nadroparin for the initial treatment of pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Nadroparin (Fraxiparine) (nadroparin)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Pulmonary Embolism, Thromboembolism | Phase 4 | Status: COMPLETED